Psoriasis is a chronic, incurable, disabling skin disease characterised by red, scaly plaques.
Approximately 23% of psoriasis patients also have an accompanying arthritis that can …

Psoriasis is a chronic inflammatory skin disease with a significant number of patients
suffering from additional joint involvement and other co-morbidities. The precise …

Introduction The aim of this study was to evaluate response and drug survival of biologic
therapy in patients with moderate to severe plaque-type psoriasis who initiated biologic …

Psoriasis is a systemic inflammatory disease. Effective management requires treatment with
agents targeting inflammation in skin, joints, and other tissues. Biologics for psoriasis are …

Background Approximately 2% of people worldwide have psoriasis, with as many as 1
million people with psoriasis in Canada alone. 1, 2 The severity of psoriasis ranges from …

Psoriasis is a chronic, immune-mediated, inflammatory skin disease that is prevalent in
about 3% of world's population and 3.2% of US adults who are 20 years and older. 1, 2 More …

Achieving treatment success among patients with moderate to severe psoriasis is a clinically
relevant and important issue facing clinicians and patients. Despite advances in systemic …

Until recently, little attention has been paid to psoriatic arthritis, perhaps because the
disease was thought to be mild and infrequent. However, it has become clear that the …

Psoriasis is a highly prevalent chronic, inflammatory multisystem disease with a
considerable impact on patients' quality of life and the healthcare system. This report …

Psoriasis is an immune-mediated inflammatory disease, with a chronic relapsing-remitting
course, which affects 2–3% of the worldwide population. The progressive acquisitions of the …